• The Pharma Fast 50

    PharmaTimes presents Alantra’s annual ranking of the fastest growing private pharma companies in the UK

  • Powerful progress

    Veeva’s predictions for the life sciences industry in 2021

  • Cash controllers

    Oli Hudson and Steve How, of Wilmington Healthcare, explore how NHS England’s new system-level funding works and the impact on prescribing for high cost drugs

News

View all

Web Exclusives

View all
Thumbnail image for Smart People: Jeff Elton

Smart People: Jeff Elton

Jeff Elton, chief executive of ConcertAI, talks to PharmaTimes about the pandemic's impact on oncology trials in the US

Thumbnail image for Predicting risk

Predicting risk

How pharma can use natural language processing for drug safety predictions

Thumbnail image for Class of 2021

Class of 2021

Drug development triumphs amidst a challenging 2020

MAGAZINE EXCLUSIVE
Thumbnail image for Care in the community

Care in the community

Mads Mikkelsen reminds us of the crucial role pharmacies play in the healthcare system and considers the adaptations they will have to make to thrive post-pandemic in a world that demands more from its high street

Thumbnail image for SMART PEOPLE: Dr Steve Cutler

SMART PEOPLE: Dr Steve Cutler

PharmaTimes talks to Dr Steve Cutler, chief executive officer at ICON plc, about the impact of the COVID pandemic and challenges of running large-scale vaccine trials

Thumbnail image for SMART PEOPLE: Jackie Williams

SMART PEOPLE: Jackie Williams

Jackie Williams, general manager, Astellas UK & Ireland, on her achievements, COVID-19, the challenges and opportunities for pharma and the need for progress in how we value innovation

Thumbnail image for Approach with intent

Approach with intent

Purpose proves itself: permission for pharma to explore better ways to partner with customers and regulators

Thought Leadership

View all
Thumbnail image for Why virtual engagement will be key to pharma strategy in 2021 and beyond

Why virtual engagement will be key to pharma strategy in 2021 and beyond

Life science companies were challenged by the sudden shift in ways of working as the COVID-19 pandemic began. But in moving critical work and even some large-scale events to virtual platforms, pharmaceutical teams learned valuable lessons and embraced new technologies that will become part of their long-term strategy.

Thumbnail image for What does the future of cancer care in the UK look like?

What does the future of cancer care in the UK look like?

The COVID-19 pandemic has brought into question how we approach care across multiple disease areas in the future. But what does this mean in cancer? Hear from Bristol Myers Squibb’s (BMS) Executive Medical Director, Hubert Bland, who believes that in order to advance in cancer care, we must learn from the COVID-19 response and adopt a collaborative approach across the healthcare industry.

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download